{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:37:53Z","timestamp":1792708673865,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":1174,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.rmed.2009.11.006","type":"journal-article","created":{"date-parts":[[2009,11,27]],"date-time":"2009-11-27T21:51:46Z","timestamp":1259358706000},"page":"668-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial"],"prefix":"10.1016","volume":"104","author":[{"given":"Duncan B.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bareille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Lindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart N.","family":"Farrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"45","key":"10.1016\/j.rmed.2009.11.006_bib1","doi-asserted-by":"crossref","first-page":"28210","DOI":"10.1074\/jbc.272.45.28210","article-title":"Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators","volume":"272","author":"Martin","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rmed.2009.11.006_bib2","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diab.44.9.1087","article-title":"Repeat treatment of obese mice with BRL 49653, a new and potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT 4 as measured by photoaffinity labeling","volume":"44","author":"Young","year":"1995","journal-title":"Diabetes"},{"issue":"8 Pt 1","key":"10.1016\/j.rmed.2009.11.006_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1164\/ajrccm.164.8.2101070","article-title":"Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling","volume":"164","author":"Benayoun","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2009.11.006_bib4","first-page":"152","article-title":"Peroxisome proliferator-activated receptors as novel targets in lung disease","volume":"134","author":"Belvisi","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2009.11.006_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/clpt.2009.41","article-title":"Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma","volume":"86","author":"Spears","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rmed.2009.11.006_bib6","doi-asserted-by":"crossref","first-page":"14983","DOI":"10.1155\/2007\/14983","article-title":"Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease","volume":"2007","author":"Ward","year":"2007","journal-title":"PPAR Res"},{"issue":"6","key":"10.1016\/j.rmed.2009.11.006_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.RES.0000014225.20727.8F","article-title":"PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis","volume":"90","author":"Marx","year":"2002","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-2478(03)00003-8","article-title":"Expression of PPARgamma in eosinophils and its functional role in survival and chemotaxis","volume":"86","author":"Ueki","year":"2003","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.abb.2003.08.006","article-title":"Peroxisome proliferator-activated receptor gamma ligands attenuate immunological symptoms of experimental allergic asthma","volume":"418","author":"Mueller","year":"2003","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.rmed.2009.11.006_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1084\/jem.20021384","article-title":"Peroxisome proliferator-activated receptors alpha and gamma down-regulate allergic inflammation and eosinophil activation","volume":"198","author":"Woerly","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.rmed.2009.11.006_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bjp.0705232","article-title":"PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect","volume":"139","author":"Trifilieff","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/diacare.25.2.401","article-title":"Improvement of asthma after administration of pioglitazone","volume":"25","author":"Hashimoto","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rmed.2009.11.006_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0022-3565(24)37268-4","article-title":"Identification of high-affinity binding sites for the insulin-sensitizer rosiglitazone (BRL 49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma","volume":"284","author":"Young","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.rmed.2009.11.006_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2005.06.010","article-title":"Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands","volume":"344","author":"Seimandi","year":"2005","journal-title":"Anal Biochem"},{"issue":"4","key":"10.1016\/j.rmed.2009.11.006_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/PL00007574","article-title":"Bronchial and bronchoalveolar inflammation in single early and dual responders after allergen inhalation challenge","volume":"175","author":"Silvestri","year":"1997","journal-title":"Lungs"},{"issue":"5\u20136","key":"10.1016\/j.rmed.2009.11.006_bib16","first-page":"273","article-title":"Course of non-specific bronchial reactivity to histamine after bronchospasm induced by allergen challenge in patients with bronchial asthma","volume":"63","author":"Grzelewska-Rzymowska","year":"1995","journal-title":"Pneumonol Alergol Pol"},{"issue":"6","key":"10.1016\/j.rmed.2009.11.006_bib17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1183\/09031936.03.00008403","article-title":"ERS Task Force. Indirect airway challenges","volume":"21","author":"Joos","year":"2003","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.rmed.2009.11.006_bib18","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1164\/ajrccm.164.7.2102135","article-title":"Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine","volume":"164","author":"van den Berge","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.rmed.2009.11.006_bib19","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2003-032103","article-title":"Evidence for a potent antiinflammatory effect of rosiglitazone","volume":"89","author":"Mohanty","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/diacare.24.2.308","article-title":"Rosiglitazone Clinical Trials Study Group. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes","volume":"24","author":"Phillips","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rmed.2009.11.006_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0091-6749(97)70196-9","article-title":"Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model","volume":"100","author":"Kidney","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2009.11.006_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1398-9995.2005.00633.x","article-title":"Differential effects of fluticasone and montelukast on allergen-induced asthma","volume":"60","author":"Palmqvist","year":"2005","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.rmed.2009.11.006_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1164\/rccm.200704-588OC","article-title":"Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma","volume":"176","author":"Singh","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2009.11.006_bib25","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.93.06091368","article-title":"Increased amount of nitric\u00a0oxide in exhaled air of asthmatics","volume":"6","author":"Alving","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2009.11.006_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(94)90931-8","article-title":"Increased nitric oxide in exhaled air of asthmatic patients","volume":"343","author":"Kharitonov","year":"1994","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.rmed.2009.11.006_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2222.2002.01309.x","article-title":"The allergen challenge","volume":"32","author":"Hansel","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.rmed.2009.11.006_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2009.11.006_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.104.074005","article-title":"Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide","volume":"312","author":"Crosby","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.rmed.2009.11.006_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00151829-200605060-00010","article-title":"Corticosteroid insensitivity in smokers with asthma: clinical evidence, mechanisms, and management","volume":"5","author":"Thomson","year":"2006","journal-title":"Treat Respir Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611109003709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611109003709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:57:57Z","timestamp":1760612277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611109003709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0954611109003709"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2009.11.006","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2009.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}